This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Eisai Company, Limited, Genox Research, Inc., Japan as Represented by General Director of Agency of National Center for Child Health & Development. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2006
Title: Gozoh Tsujimoto: Innovator in Allergy Testing
Introduction
Gozoh Tsujimoto is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medical research, particularly in the area of allergy testing. His innovative approach has led to advancements that can potentially improve the diagnosis and treatment of allergic diseases.
Latest Patents
Gozoh Tsujimoto holds a patent for a method of testing for allergic diseases. The patent describes a differential display method used to identify a gene whose expression level in eosinophils collected from patients with atopic dermatitis varies between the exacerbation and remission stages. The gene '2090-05' was isolated, showing a significant increase in expression in eosinophils of patients during the remission stage. This gene has potential applications in testing for allergic diseases and screening for candidate compounds for therapeutic agents.
Career Highlights
Throughout his career, Gozoh Tsujimoto has held prominent positions in various organizations. He has served as the General Director of the Agency of National Center for Child Health & Development in Japan. Additionally, he has worked with Eisai Company, Limited, contributing to the advancement of medical research and innovation.
Collaborations
Gozoh Tsujimoto has collaborated with notable colleagues, including Takeshi Nagasu and Eiki Takahashi. Their combined efforts have furthered research in the field of allergy testing and treatment.
Conclusion
Gozoh Tsujimoto's work in developing methods for testing allergic diseases showcases his dedication to improving healthcare. His innovative contributions have the potential to make a significant impact on the diagnosis and treatment of allergies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile